| 1 |
35163465 | Up-Regulation of Cyclooxygenase-2 (COX-2) Expression by Temozolomide (TMZ) in Human Glioblastoma (GBM) Cell Lines. | 2022 Jan 28 |
2 |
| 2 |
34072831 | NBM-BMX, an HDAC8 Inhibitor, Overcomes Temozolomide Resistance in Glioblastoma Multiforme by Downregulating the β-Catenin/c-Myc/SOX2 Pathway and Upregulating p53-Mediated MGMT Inhibition. | 2021 May 31 |
4 |
| 3 |
34230224 | Long Noncoding RNA PVT1 Promotes Stemness and Temozolomide Resistance through miR-365/ELF4/SOX2 Axis in Glioma. | 2021 Jun 30 |
1 |
| 4 |
32439916 | LncRNA SOX2OT promotes temozolomide resistance by elevating SOX2 expression via ALKBH5-mediated epigenetic regulation in glioblastoma. | 2020 May 21 |
3 |
| 5 |
32622951 | Cyclopamine sensitizes glioblastoma cells to temozolomide treatment through Sonic hedgehog pathway. | 2020 Sep 15 |
1 |
| 6 |
30980849 | miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2. | 2019 Jun 1 |
2 |
| 7 |
30172378 | FoxG1 facilitates proliferation and inhibits differentiation by downregulating FoxO/Smad signaling in glioblastoma. | 2018 Sep 26 |
1 |
| 8 |
28241425 | Heat Shock Factor 1 Depletion Sensitizes A172 Glioblastoma Cells to Temozolomide via Suppression of Cancer Stem Cell-Like Properties. | 2017 Feb 22 |
2 |
| 9 |
28526577 | Changes in tumor cell heterogeneity after chemotherapy treatment in a xenograft model of glioblastoma. | 2017 Jul 25 |
1 |
| 10 |
26878385 | mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance. | 2016 |
2 |
| 11 |
27791206 | Metformin treatment reduces temozolomide resistance of glioblastoma cells. | 2016 Nov 29 |
1 |
| 12 |
25605243 | Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors. | 2015 Feb 20 |
1 |